Hwei-Ling Cheng
Howard Hughes Medical Institute(US)Harvard University(US)
Publications by Year
Research Areas
Sirtuins and Resveratrol in Medicine, DNA Repair Mechanisms, Adipose Tissue and Metabolism, PARP inhibition in cancer therapy, CRISPR and Genetic Engineering
Most-Cited Works
- → Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6(2006)1,611 cited
- → Mammalian Sir2 Homolog SIRT3 Regulates Global Mitochondrial Lysine Acetylation(2007)1,209 cited
- → Late embryonic lethality and impaired V (D)J recombination in mice lacking DNA ligase IV(1998)583 cited
- → Tissue-specific regulation of SIRT1 by calorie restriction(2008)553 cited
- → Mice Lacking Histone Deacetylase 6 Have Hyperacetylated Tubulin but Are Viable and Develop Normally(2008)550 cited
- → Growth Retardation and Leaky SCID Phenotype of Ku70-Deficient Mice(1997)454 cited
- → Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress(2005)260 cited
- → RAB22 and RAB163/mouse BRCA2: Proteins that specifically interact with the RAD51 protein(1997)238 cited
- → Lymphocyte-Specific Compensation for XLF/Cernunnos End-Joining Functions in V(D)J Recombination(2008)188 cited
- → The NAD-dependent deacetylase SIRT2 is required for programmed necrosis(2012)136 cited